1
|
Goethals LR, Bos TJ, Baeyens L, De Geeter F, Devoogdt N, Lahoutte T. Camelid reporter gene imaging: a generic method for in vivo cell tracking. EJNMMI Res 2014; 4:32. [PMID: 25024930 PMCID: PMC4086443 DOI: 10.1186/s13550-014-0032-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2014] [Accepted: 06/03/2014] [Indexed: 11/17/2022] Open
Abstract
Background To combine the sensitivity of bioluminescent imaging (BLI) with the 3D and quantitative properties of pinhole single-photon emission computed tomography (SPECT)/micro-computed tomography (CT) (phSPECT/micro-CT), we generated stable cell lines that express a yellow-fluorescent protein (YFP) and Gaussia luciferase (GLuc) fusion protein (YFP/GLuc). For in vivo phSPECT detection of this YFP/GLuc protein, a nanobody, targeted against yellow and green fluorescent proteins (anti-YFP-Nb), was site specifically labelled with 99mTc. Methods Human embryonic kidney cells (HEK293T) were cultured and passaged every 3 days. 10E5 cells were transduced with YFP/GLuc-containing vector: both membrane-targeted (MT-YFP/GLuc) and non-targeted (YFP/GLuc) fusion proteins were developed. These vectors were compared against a SKOV-3 cell line stably expressing green fluorescent-firefly luciferase (GFP/Fluc) and HEK293T cells expressing red fluorescent protein in combination with a Gaussia luciferase (Red/GLuc). Transduction efficiencies were scored by fluorescence microscopy, and transduced cells were enriched by fluorescence-activated cell sorting (FACS). GLuc and FLuc functionality was tested in vitro by list-mode BLI. Subsequently, cells were transplanted subcutaneously in athymic (nu/nu) mice (MT-YFP/GLuc: n = 4, YFP/GLuc: n = 6, GFP/FLuc: n = 6, Red/GLuc: n = 4). Labelling efficiency of anti-YFP-Nb was measured using instant thin layer chromatography. One week after transplantation, 99mTc-labelled anti-YFP-Nb was injected intravenously and pinhole (ph) SPECT/micro-CT was performed, followed by in vivo BLI. Results Cells showed high levels of fluorescence after transduction. The cells containing the MT-YFP/GLuc were positive on fluorescence microscopy, with the fluorescent signal confined to the cell membrane. After cell sorting, transduced cells were assayed by BLI and showed a significantly higher light output both in vitro and in vivo compared with non-transduced HEK293T cells. The anti-YFP-Nb labelling efficiency was 98%, and subsequent phSPECT/micro-CT demonstrated visible cell binding and significantly higher transplant-to-muscle ratio for both the MT-YFP/GLuc and YFP/GLuc transplanted cells, compared with the GFP/FLuc and Red/GLuc group. Conclusion This study provides a proof of principle for a nanobody-based cell tracking method, using a YFP/GLuc fusion protein and anti-YFP-Nb in a model of subcutaneously transplanted transduced HEK293T cells.
Collapse
Affiliation(s)
- Lode Ry Goethals
- In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Laarbeeklaan 103, Jette 1090, Belgium ; Department of Radiology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Jette 1090, Belgium
| | - Tomas J Bos
- Department of Cellular and Molecular Medicine, UC San Diego, 9500 Gilman Drive, La Jolla 92093, CA, USA
| | - Luc Baeyens
- Beta Cell Neogenesis, Vrije Universiteit Brussel, Laarbeeklaan103, Jette 1090, Belgium
| | - Frank De Geeter
- In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Laarbeeklaan 103, Jette 1090, Belgium
| | - Nick Devoogdt
- In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Laarbeeklaan 103, Jette 1090, Belgium
| | - Tony Lahoutte
- In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Laarbeeklaan 103, Jette 1090, Belgium ; Department of Nuclear Medicine, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Jette 1090, Belgium
| |
Collapse
|
2
|
Niers JM, Chen JW, Lewandrowski G, Kerami M, Garanger E, Wojtkiewicz G, Waterman P, Keliher E, Weissleder R, Tannous BA. Single reporter for targeted multimodal in vivo imaging. J Am Chem Soc 2012; 134:5149-56. [PMID: 22397453 PMCID: PMC3310895 DOI: 10.1021/ja209868g] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
We have developed a multifaceted, highly specific reporter for multimodal in vivo imaging and applied it for detection of brain tumors. A metabolically biotinylated, membrane-bound form of Gaussia luciferase was synthesized, termed mbGluc-biotin. We engineered glioma cells to express this reporter and showed that brain tumor formation can be temporally imaged by bioluminescence following systemic administration of coelenterazine. Brain tumors expressing this reporter had high sensitivity for detection by magnetic resonance and fluorescence tomographic imaging upon injection of streptavidin conjugated to magnetic nanoparticles or fluorophore, respectively. Moreover, single photon emission computed tomography showed enhanced imaging of these tumors upon injection with streptavidin complexed to (111)In-DTPA-biotin. This work shows for the first time a single small reporter (∼40 kDa) which can be monitored with most available molecular imaging modalities and can be extended for single cell imaging using intravital microscopy, allowing real-time tracking of any cell expressing it in vivo.
Collapse
Affiliation(s)
- Johanna M Niers
- Experimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Department of Neurology, Massachusetts General Hospital, Boston, USA
- Neuro-oncology Research Group, Department of Neurosurgery, VU Medical Center, Cancer Center Amsterdam, 1007 MB Amsterdam, The Netherlands
| | - John W Chen
- Center for Systems Biology, Massachusetts General Hospital, Boston, USA
- Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, USA
| | - Grant Lewandrowski
- Experimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Department of Neurology, Massachusetts General Hospital, Boston, USA
| | - Mariam Kerami
- Experimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Department of Neurology, Massachusetts General Hospital, Boston, USA
- Neuro-oncology Research Group, Department of Neurosurgery, VU Medical Center, Cancer Center Amsterdam, 1007 MB Amsterdam, The Netherlands
| | | | - Greg Wojtkiewicz
- Center for Systems Biology, Massachusetts General Hospital, Boston, USA
- Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, USA
| | - Peter Waterman
- Center for Systems Biology, Massachusetts General Hospital, Boston, USA
- Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, USA
| | - Edmund Keliher
- Center for Systems Biology, Massachusetts General Hospital, Boston, USA
- Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, USA
| | - Ralph Weissleder
- Center for Systems Biology, Massachusetts General Hospital, Boston, USA
- Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, USA
| | - Bakhos A. Tannous
- Experimental Therapeutics and Molecular Imaging Laboratory, Neuroscience Center, Department of Neurology, Massachusetts General Hospital, Boston, USA
- Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital, Boston, USA
- Program in Neuroscience, Harvard Medical School, Boston, USA
| |
Collapse
|
3
|
Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proc Natl Acad Sci U S A 2008; 105:4733-8. [PMID: 18326627 DOI: 10.1073/pnas.0710650105] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
A growing number of cellular mRNAs are thought to possess internal ribosome entry sites (IRESs), sequences that permit translation of a transcript independent of its 5' end and cap structure. Although dicistronic assays are the canonical method of testing sequences for IRES activity, they may produce false-positive results if unanticipated monocistronic RNAs arise from the dicistronic construct used. Using a dicistronic reporter system and a green fluorescent protein-tagged retrovirus to evaluate six previously reported cellular IRESs, we found that four contain 3' splice sites whose activity was required for apparent IRES function and which resulted in formation of monocistronic transcripts by splicing. Bioinformatic analysis revealed that the 3' splice sites identified in three of these putative IRESs are used in their native mRNAs and that the fourth is likely an artifactual sequence created during cDNA cloning. Our findings demonstrate a need for reexamination of other reported cellular IRESs by using careful RNA structural analysis to rule out splicing as the source of perceived IRES activity.
Collapse
|
4
|
|
5
|
Farrow PJ, Barrett LB, Stevenson M, Fisher KD, Finn J, Spice R, Allan MA, Berry M, Logan A, Seymour LW, Read ML. Cytoplasmic expression systems triggered by mRNA yield increased gene expression in post-mitotic neurons. Nucleic Acids Res 2006; 34:e80. [PMID: 16835307 PMCID: PMC1500874 DOI: 10.1093/nar/gkl442] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2006] [Revised: 05/26/2006] [Accepted: 06/07/2006] [Indexed: 01/06/2023] Open
Abstract
Non-viral vectors are promising vehicles for gene therapy but delivery of plasmid DNA to post-mitotic cells is challenging as nuclear entry is particularly inefficient. We have developed and evaluated a hybrid mRNA/DNA system designed to bypass the nuclear barrier to transfection and facilitate cytoplasmic gene expression. This system, based on co-delivery of mRNA(A64) encoding for T7 RNA polymerase (T7 RNAP) with a T7-driven plasmid, produced between 10- and 2200-fold higher gene expression in primary dorsal root ganglion neuronal (DRGN) cultures isolated from Sprague-Dawley rats compared to a cytomegalovirus (CMV)-driven plasmid, and 30-fold greater expression than the enhanced T7-based autogene plasmid pR011. Cell-free assays and in vitro transfections highlighted the versatility of this system with small quantities of T7 RNAP mRNA required to mediate expression at levels that were significantly greater than with the T7-driven plasmid alone or supplemented with T7 RNAP protein. We have also characterized a number of parameters, such as mRNA structure, intracellular stability and persistence of each nucleic acid component that represent important factors in determining the transfection efficiency of this hybrid expression system. The results from this study demonstrate that co-delivery of mRNA is a promising strategy to yield increased expression with plasmid DNA, and represents an important step towards improving the capability of non-viral vectors to mediate efficient gene transfer in cell types, such as in DRGN, where the nuclear membrane is a significant barrier to transfection.
Collapse
Affiliation(s)
- Paul J. Farrow
- Department of Clinical Pharmacology, University of OxfordOxford OX2 6HE, UK
- Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical SchoolBoston, MA 02129, USA
- Department of Biochemistry and Molecular Biology, University of British ColumbiaVancouver, British Columbia, Canada
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| | - Lee B. Barrett
- Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical SchoolBoston, MA 02129, USA
| | - Mark Stevenson
- Department of Clinical Pharmacology, University of OxfordOxford OX2 6HE, UK
- Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical SchoolBoston, MA 02129, USA
- Department of Biochemistry and Molecular Biology, University of British ColumbiaVancouver, British Columbia, Canada
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| | - Kerry D. Fisher
- Department of Clinical Pharmacology, University of OxfordOxford OX2 6HE, UK
- Department of Anesthesia and Critical Care, Massachusetts General Hospital and Harvard Medical SchoolBoston, MA 02129, USA
- Department of Biochemistry and Molecular Biology, University of British ColumbiaVancouver, British Columbia, Canada
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| | - Jonathan Finn
- Department of Biochemistry and Molecular Biology, University of British ColumbiaVancouver, British Columbia, Canada
| | - Rachel Spice
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| | - Michael A. Allan
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| | - Martin Berry
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| | - Ann Logan
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| | - Leonard W. Seymour
- To whom correspondence should be addressed. Tel: +44 1865 224986; Fax: +44 1865 224538;
| | - Martin L. Read
- Molecular Neuroscience Group, Department of Medicine, University of BirminghamBirmingham B15 2TT, UK
| |
Collapse
|
6
|
Finn JD, Wong T, Cullis PR. Investigation of factors responsible for cell line cytoplasmic expression differences. BMC Mol Biol 2005; 6:11. [PMID: 15888202 PMCID: PMC1134659 DOI: 10.1186/1471-2199-6-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2005] [Accepted: 05/11/2005] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Previous work has described a novel cytoplasmic expression system that results in a 20-fold increase in the levels of gene expression over a standard CMV-based nuclear expression system, as compared with a 2-3 fold increase seen with previous similar systems. While this increase was seen with BHK and Neuro-2a cells, further studies revealed that some cell lines, such as COS-7, demonstrated relatively poor levels of cytoplasmic expression. The objective of this study was to determine what factors were responsible for the different expression levels between BHK (a high expressing cell line) and COS-7 (a low expressing cell line). RESULTS The main findings of this work are that the individual elements of the cytoplasmic expression system (such as the T7 RNAP gene and Internal Ribosome Entry Sequence) are functioning similarly in both cell types. Both cell types were found to have the same amount of cytosolic nuclease activity, and that the cells appeared to have differences in the intra-cellular processing of DNA-cationic lipid complexes. CONCLUSION After exploring many factors, it was found that differences in the intra-cellular processing of the DNA-cationic lipid complex was the most probable factor responsible for the difference in cytoplasmic gene expression.
Collapse
Affiliation(s)
- Jonathan D Finn
- Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, B.C., Canada
| | - Tabitha Wong
- Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, B.C., Canada
| | - Pieter R Cullis
- Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, B.C., Canada
- Inex Pharmaceuticals Corp., Burnaby, B.C., Canada
| |
Collapse
|